{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T18:45:11Z","timestamp":1743446711017},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00063-023-01050-7","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T14:02:56Z","timestamp":1693317776000},"page":"445-453","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Respiratorische Virusinfektionen","Respiratory viral infections"],"prefix":"10.1007","volume":"118","author":[{"given":"Janina","family":"Trauth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"key":"1050_CR1","unstructured":"AWMF Leitlinienregister (2023) https:\/\/register.awmf.org\/de\/leitlinien\/detail\/113-001LG. Zugegriffen: 27. M\u00e4rz 2023"},{"key":"1050_CR2","doi-asserted-by":"publisher","first-page":"840639","DOI":"10.3389\/fphar.2022.840639","volume":"13","author":"L Zhao","year":"2022","unstructured":"Zhao\u00a0L, Li\u00a0S, Zhong\u00a0W (2022) Mechanism of action of small-molecule agents in ongoing clinical trials for SARS-CoV-2: a review. Front Pharmacol 13:840639","journal-title":"Front Pharmacol"},{"key":"1050_CR3","doi-asserted-by":"publisher","unstructured":"Jayk Bernal A, Silva da Gomes MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V et al (2022) Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N\u00a0Engl J\u00a0Med 386(6):509\u2013520. https:\/\/doi.org\/10.1056\/NEJMoa2116044","DOI":"10.1056\/NEJMoa2116044"},{"issue":"12","key":"1050_CR4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S2213-2600(22)00297-1","volume":"10","author":"APJ Vlaar","year":"2022","unstructured":"Vlaar\u00a0APJ, Witzenrath\u00a0M, van Paassen\u00a0P, Heunks\u00a0LMA, Mourvillier\u00a0B, de Bruin\u00a0S et al (2022) Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a\u00a0multicentre, double-blind, randomised, placebo-controlled, phase 3\u00a0trial. Lancet Respir Med 10(12):1137\u20131146","journal-title":"Lancet Respir Med"},{"key":"1050_CR5","doi-asserted-by":"publisher","unstructured":"Koch J, Piechotta V, Berner R, Bogdan C, Burchard G, Heininger U, Hummers E, von Kries R, Ledig T, Littmann M, Meerpohl J, Mertens T, R\u00f6bl-Mathieu M, van der Sande M, Sander LE, Terhardt M, \u00dcberla K, Vygen-Bonnet S, Wichmann O, Wicker S, Wiedermann-Schmidt U, Widders G, Zepp F (2023) Empfehlung der STIKO zur Implementierung der COVID-19-Impfung in die Empfehlungen der STIKO 2023 und die dazugeh\u00f6rige wissenschaftliche Begr\u00fcndung. Epid Bull 21:7\u201348. https:\/\/doi.org\/10.25646\/11461.3","DOI":"10.25646\/11461.3"},{"issue":"8","key":"1050_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S2213-2600(22)00131-X","volume":"10","author":"F Zhu","year":"2022","unstructured":"Zhu\u00a0F, Zhuang\u00a0C, Chu\u00a0K, Zhang\u00a0L, Zhao\u00a0H, Huang\u00a0S et al (2022) Safety and immunogenicity of a\u00a0live-attenuated influenza virus vector-based intranasal SARS-coV\u20112 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2\u00a0trials. Lancet Respir Med 10(8):749\u2013760","journal-title":"Lancet Respir Med"},{"issue":"17","key":"1050_CR7","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1056\/NEJMoa2212616","volume":"388","author":"LF Pittet","year":"2023","unstructured":"Pittet\u00a0LF, Messina\u00a0NL, Orsini\u00a0F, Moore\u00a0CL, Abruzzo\u00a0V, Barry\u00a0S et al (2023) Randomized trial of BCG vaccine to protect against Covid-19 in health care workers. N\u00a0Engl J Med 388(17):1582\u20131596","journal-title":"N Engl J Med"},{"issue":"4","key":"1050_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa1702090","volume":"378","author":"JC Kwong","year":"2018","unstructured":"Kwong\u00a0JC, Schwartz\u00a0KL, Campitelli\u00a0MA, Chung\u00a0H, Crowcroft\u00a0NS, Karnauchow\u00a0T et al (2018) Acute myocardial infarction after laboratory-confirmed influenza infection. N\u00a0Engl J Med 378(4):345\u2013353","journal-title":"N Engl J Med"},{"issue":"8","key":"1050_CR9","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/cid\/ciac217","volume":"75","author":"C Su","year":"2022","unstructured":"Su\u00a0C, Chan\u00a0KA, Huang\u00a0CT, Fang\u00a0CT (2022) Inhaled zanamivir vs oral oseltamivir to prevent influenza-related hospitalization or death: a nationwide population-based quasi-experimental study. Clin Infect Dis 75(8):1273\u20131279","journal-title":"Clin Infect Dis"},{"issue":"13","key":"1050_CR10","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s40265-018-0981-8","volume":"78","author":"LJ Scott","year":"2018","unstructured":"Scott\u00a0LJ (2018) Peramivir: a review in uncomplicated influenza. Drugs 78(13):1363\u20131370. https:\/\/doi.org\/10.1007\/s40265-018-0981-8","journal-title":"Drugs"},{"issue":"10","key":"1050_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","volume":"379","author":"FG Hayden","year":"2018","unstructured":"Hayden\u00a0FG, Sugaya\u00a0N, Hirotsu\u00a0N, Lee\u00a0N, de Jong\u00a0MD, Hurt\u00a0AC et\u00a0al (2018) Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N\u00a0Engl J Med 379(10):913\u2013923","journal-title":"N Engl J Med"},{"issue":"10","key":"1050_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1021\/acsinfecdis.7b00142","volume":"3","author":"ML Shaw","year":"2017","unstructured":"Shaw\u00a0ML (2017) The next wave of influenza drugs. ACS Infect Dis 3(10):691\u2013694","journal-title":"ACS Infect Dis"},{"issue":"5","key":"1050_CR13","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S1473-3099(21)00469-2","volume":"22","author":"D Kumar","year":"2022","unstructured":"Kumar\u00a0D, Ison\u00a0MG, Mira\u00a0J\u2011P, Welte\u00a0T, Hwan Ha\u00a0J, Hui\u00a0DS et al (2022) Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a\u00a0randomised, parallel-group, double-blind, placebo-controlled, superiority trial. Lancet Infect Dis 22(5):718\u2013730","journal-title":"Lancet Infect Dis"},{"key":"1050_CR14","doi-asserted-by":"publisher","unstructured":"Wang C-H, Chung F-T, Lin S-M, Huang S-Y, Chou C-L, Lee K-Y, Lin T-Y, Kuo H-P (2014) Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure. Crit Care Med 42(2):313\u2013321. https:\/\/doi.org\/10.1097\/CCM.0b013e3182a2727d","DOI":"10.1097\/CCM.0b013e3182a2727d"},{"key":"1050_CR15","doi-asserted-by":"publisher","unstructured":"Johansen ND, Vaduganathan M, Bhatt AS, Lee SG, Modin D, Claggett BL et al (2023) Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial. Lancet 401(10382):1103\u20131114. https:\/\/doi.org\/10.1016\/S0140-6736(23)00349-5","DOI":"10.1016\/S0140-6736(23)00349-5"},{"key":"1050_CR16","doi-asserted-by":"publisher","unstructured":"Schumacher S, Salmanton-Garc\u00eda J, Liekweg A, Rolfes M, Seidel D, Mellinghoff SC et al (2023) Increasing influenza vaccination coverage in healthcare workers: analysis of an intensified on-site vaccination campaign during the COVID-19 pandemic. Infection. https:\/\/doi.org\/10.1007\/s15010-023-02007-w","DOI":"10.1007\/s15010-023-02007-w"},{"issue":"12","key":"1050_CR17","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMcibr2215281","volume":"388","author":"KM Neuzil","year":"2023","unstructured":"Neuzil\u00a0KM (2023) An mRNA influenza vaccine\u2014could it deliver? N\u00a0Engl J Med 388(12):1139\u20131141","journal-title":"N Engl J Med"},{"issue":"6","key":"1050_CR18","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/cid\/ciab595","volume":"74","author":"AR Branche","year":"2022","unstructured":"Branche\u00a0AR, Saiman\u00a0L, Walsh\u00a0EE, Falsey\u00a0AR, Sieling\u00a0WD, Greendyke\u00a0W et\u00a0al (2022) Incidence of respiratory syncytial virus infection among hospitalized adults, 2017\u20132020. Clin Infect Dis 74(6):1004\u20131011","journal-title":"Clin Infect Dis"},{"issue":"11","key":"1050_CR19","doi-asserted-by":"publisher","first-page":"e4384","DOI":"10.1093\/cid\/ciaa1612","volume":"73","author":"Z Haddadin","year":"2021","unstructured":"Haddadin\u00a0Z, Beveridge\u00a0S, Fernandez\u00a0K, Rankin\u00a0DA, Probst\u00a0V, Spieker\u00a0AJ et\u00a0al (2021) Respiratory syncytial virus disease severity in young children. Clin Infect Dis 73(11):e4384\u2013e4391","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1050_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.chom.2021.11.006","volume":"30","author":"T Zohar","year":"2022","unstructured":"Zohar\u00a0T, Hsiao\u00a0JC, Mehta\u00a0N, Das\u00a0J, Devadhasan\u00a0A, Karpinski\u00a0W et\u00a0al (2022) Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates. Cell Host Microbe 30(1):41\u201352.e5","journal-title":"Cell Host Microbe"},{"issue":"1","key":"1050_CR21","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1093\/cid\/ciaa730","volume":"73","author":"N Prasad","year":"2021","unstructured":"Prasad\u00a0N, Walker\u00a0TA, Waite\u00a0B, Wood\u00a0T, Trenholme\u00a0AA, Baker\u00a0MG et al (2021) Respiratory syncytial virus-associated hospitalizations among adults with chronic medical conditions. Clin Infect Dis 73(1):e158\u2013e163","journal-title":"Clin Infect Dis"},{"key":"1050_CR22","doi-asserted-by":"publisher","first-page":"105399","DOI":"10.1016\/j.jcv.2023.105399","volume":"161","author":"A Andreas","year":"2023","unstructured":"Andreas\u00a0A, Doris\u00a0L, Frank\u00a0K, Michael\u00a0K (2023) Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: risk factors, symptomatology and clinical course compared to influenza A \/ B and the original SARS-coV\u20112 strain. J\u00a0Clin Virol 161:105399","journal-title":"J Clin Virol"},{"issue":"9","key":"1050_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/NEJMoa2110275","volume":"386","author":"LL Hammitt","year":"2022","unstructured":"Hammitt\u00a0LL, Dagan\u00a0R, Yuan\u00a0Y, Baca Cots\u00a0M, Bosheva\u00a0M, Madhi\u00a0SA et al (2022) Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N\u00a0Engl J Med 386(9):837\u2013846","journal-title":"N Engl J Med"},{"issue":"5","key":"1050_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41579-022-00717-w","volume":"20","author":"A Du Toit","year":"2022","unstructured":"Du Toit\u00a0A (2022) Evaluating an RSV inhibitor. Nat Rev Microbiol 20(5):254","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"1050_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1165\/rcmb.2021-0457ED","volume":"66","author":"YA Mebratu","year":"2022","unstructured":"Mebratu\u00a0YA, Tesfaigzi\u00a0Y (2022) Is IL-1\u03b2 a\u00a0target for reducing hospitalization of infants infected with respiratory syncytial virus? Am J Respir Cell Mol Biol 66(3):248\u2013249","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1050_CR26","doi-asserted-by":"publisher","first-page":"107712","DOI":"10.1016\/j.pharmthera.2020.107712","volume":"220","author":"F Elawar","year":"2021","unstructured":"Elawar\u00a0F, Oraby\u00a0AK, Kieser\u00a0Q, Jensen\u00a0LD, Culp\u00a0T, West\u00a0FG et\u00a0al (2021) Pharmacological targets and emerging treatments for respiratory syncytial virus bronchiolitis. Pharmacol Ther 220:107712","journal-title":"Pharmacol Ther"},{"issue":"7","key":"1050_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1056\/NEJMp2216358","volume":"388","author":"BS Graham","year":"2023","unstructured":"Graham\u00a0BS (2023) The journey to RSV vaccines\u2014heralding an era of structure-based design. N\u00a0Engl J Med 388(7):579\u2013581","journal-title":"N Engl J Med"},{"issue":"12","key":"1050_CR28","doi-asserted-by":"publisher","first-page":"e2112410119","DOI":"10.1073\/pnas.2112410119","volume":"119","author":"JA Lewnard","year":"2022","unstructured":"Lewnard\u00a0JA, Fries\u00a0LF, Cho\u00a0I, Chen\u00a0J, Laxminarayan\u00a0R (2022) Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus. Proc Natl Acad Sci U S\u00a0A 119(12):e2112410119. https:\/\/doi.org\/10.1073\/pnas.2112410119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"25","key":"1050_CR29","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1056\/NEJMoa2116154","volume":"386","author":"B Schmoele-Thoma","year":"2022","unstructured":"Schmoele-Thoma\u00a0B, Zareba\u00a0AM, Jiang\u00a0Q, Maddur\u00a0MS, Danaf\u00a0R, Mann\u00a0A et al (2022) Vaccine efficacy in adults in a\u00a0respiratory syncytial virus challenge study. N\u00a0Engl J Med 386(25):2377\u20132386","journal-title":"N Engl J Med"},{"key":"1050_CR30","unstructured":"https:\/\/path.org\/resources\/rsv-vaccine-and-mab-snapshot\/. Zugegriffen: 19. Juni 2023"},{"issue":"12","key":"1050_CR31","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1093\/cid\/ciab969","volume":"74","author":"A de Zwart","year":"2022","unstructured":"de Zwart\u00a0A, Riezebos-Brilman\u00a0A, Lunter\u00a0G, Vonk\u00a0J, Glanville\u00a0AR, Gottlieb\u00a0J et al (2022) Respiratory syncytial virus, human metapneumovirus, and parainfluenza virus infections in lung transplant recipients: a systematic review of outcomes and treatment strategies. Clin Infect Dis 74(12):2252\u20132260","journal-title":"Clin Infect Dis"},{"key":"1050_CR32","doi-asserted-by":"publisher","DOI":"10.25646\/11428","volume-title":"ARE-Wochenbericht","author":"S Buda","year":"2023","unstructured":"Buda\u00a0S, D\u00fcrrwald\u00a0R, Biere\u00a0B, Reiche\u00a0J, Buchholz\u00a0U, Tolksdorf\u00a0K, Schilling\u00a0J, Goerlitz\u00a0L, Streib\u00a0V, Preu\u00df\u00a0U, Prahm\u00a0K, Krupka\u00a0S, Haas\u00a0W, AGI-Studiengruppe (2023) ARE-Wochenbericht Bd. 18. Arbeitsgemeinschaft Influenza \u2013 Robert Koch-Institut https:\/\/doi.org\/10.25646\/11428"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-023-01050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-023-01050-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-023-01050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T15:17:35Z","timestamp":1694704655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-023-01050-7"}},"subtitle":["Unter besonderer Ber\u00fccksichtigung des Severe Acute Respiratory Syndrome Coronavirus 2 und der Influenza-Viren","Under special consideration of severe acute respiratory syndrome coronavirus 2 and influenza viruses"],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1007\/s00063-023-01050-7","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"15 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Trauth ist als Referentin f\u00fcr die Fa. GSK t\u00e4tig, an Studiendurchf\u00fchrungen der Fa. Janssen Pharmaceuticals beteiligt und erh\u00e4lt Reise-Sponsoring der Fa. Gilead.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von der Autorin keine Studien an Menschen oder Tieren durchgef\u00fchrt.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}